Your Best Stock

Medtronic MDT

$89.11
−$0.19 (-0.21%)
Market open · Sep 24, 2:00 pm ET
After hours $89.32 +0.02%
Open$89.62
Prev close$89.30
Day range$88.82 – $90.28
Volume4.96M
Market cap$113.98B
P/E (TTM)21.9
Dividend yield3.20%

Earnings

Average move on report day±3.6%last 16 reports
Closed higher7 of 1644% of the time
Best reaction+5.7%
Worst reaction-7.3%

Stock move on the day after each report

-4.5%2023/Q4+2.6%2024/Q1+4.6%2024/Q2+1.7%2024/Q3-5.1%2024/Q4+0.7%2025/Q1-3.0%2025/Q2-7.3%2025/Q3-2.3%2025/Q4-3.1%2026/Q3+5.7%2026/Q4+1.5%2027/Q1
QuarterReport dateTimingImplied moveActual moveVersus implied
2027/Q11 Sep 2026Pre Market±4.5%+1.53%Within range
2026/Q43 Jun 2026Pre Market±3.4%+5.69%Bigger than priced
2026/Q317 Feb 2026Pre Market±4.5%-3.10%Within range
2025/Q421 May 2025Pre Market±3.7%-2.27%Within range
2025/Q318 Feb 2025Pre Market±3.4%-7.26%Bigger than priced
2025/Q219 Nov 2024Pre Market±3.4%-2.96%Within range
2025/Q120 Aug 2024Pre Market±3.3%+0.66%Within range
2024/Q423 May 2024Pre Market±3.6%-5.11%Bigger than priced
2024/Q320 Feb 2024Pre Market±3.6%+1.69%Within range
2024/Q221 Nov 2023Pre Market±3.0%+4.60%Bigger than priced
2024/Q122 Aug 2023Pre Market±3.4%+2.59%Within range
2023/Q425 May 2023–±3.1%-4.51%Bigger than priced
2023/Q321 Feb 2023Pre Market±3.7%+0.81%Within range
2023/Q222 Nov 2022Pre Market±3.2%-5.30%Bigger than priced
2023/Q123 Aug 2022Pre Market±3.5%-3.08%Within range
2022/Q426 May 2022–±4.0%-5.78%Bigger than priced

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2027/Q1

By business line

  • Cardiovascular$3.93B 40.3%
  • Neuroscience$2.68B 27.4%
  • Medical Surgical$2.28B 23.4%
  • Other Operating Segment$872.00M 8.9%

Latest reported quarter: Q1, ended Jul 2026

Revenue$9.76B+13.7% YoY
Operating profit$1.84B+21.1% YoY
Net profit$1.48B+41.3% YoY
Diluted EPS$1.14+40.7% YoY
Free cash flow$1.29B+120.9% YoY
Operating cash flow$1.79B

Revenue, last 8 quarters

$8.4BOct '24$8.3BJan '25$8.9BApr '25$8.6BJul '25$9.0BOct '25$9.0BJan '26$9.8BApr '26$9.8BJul '26

Net profit, last 8 quarters

$1.3BOct '24$1.3BJan '25$1.1BApr '25$1.0BJul '25$1.4BOct '25$1.2BJan '26$1.3BApr '26$1.5BJul '26

Profitability & balance sheet

Gross margin65.0%
Operating margin19.0%
Net margin13.9%
Return on equity10.7%
Return on assets5.7%
Return on invested capital7.5%
Current ratio2.07
Liabilities / assets45.5%
Cash & investments$8.82B
Total debt$28.15B
Net cash (debt)-$19.33B
Free cash flow / sales16.3%
Scroll to Top